Accelsiors CRO
Olga Ivanova is a seasoned professional in business development within the clinical research organization (CRO) sector, currently serving as the Director of Business Development at Accelsiors CRO since October 2022. Accelsiors CRO specializes in oncology, hepatology, and biosimilar drug development, operating across 40 countries worldwide. Prior to this role, Olga held positions as Business Development Director at Flex Databases, Associate Director of Business Development and Sales at Cromos Pharma, and Head of Business Development at OCT – Clinical Trials, where significant contributions were made to clinical trial services. Additional experience includes various roles at PSI CRO AG, where emphasis was placed on project management and client communication.
Accelsiors CRO
1 followers
Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development. Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives. Accelsiors expertise includes studies in the following areas: • Biosimilars • Complex Generics • Endocrinology • Hepatology • Infectious Disease • Inflammatory Disease • Nephrology • Neurology • Oncology • Pulmonary • Rare Diseases • Rheumatology We serve a global Customer base, which ranges from emerging biotechnology companies to multi-national pharmaceutical companies. Accelsiors is committed to establishing meaningful collaborations with our Sponsors and executing studies, regardless of size and scope, with quality being the key driver in all that we do.